摘要
Chimeric antigen receptor(CAR)-T-cell therapies have exhibited remarkable efficacy in the treatment of hematologic malignancies,with 9 CAR-T-cell products currently available.Furthermore,CAR-T cells have shown promising potential for expanding their therapeutic applications to diverse areas,including solid tumors,myocardial fibrosis,and autoimmune and infectious diseases.Despite these advancements,significant challenges pertaining to treatment-related toxic reactions and relapses persist.Consequently,current research efforts are focused on addressing these issues to enhance the safety and efficacy of CAR-T cells and reduce the relapse rate.This article provides a comprehensive overview of the present state of CAR-T-cell therapies,including their achievements,existing challenges,and potential future developments.